ProFibrix

About:

ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.

Website: http://www.profibrix.com

Top Investors: Index Ventures, Inkef, Gilde Healthcare, Vesalius Biocapital Partners

Description:

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004